Research/art/teacher profile of a person
Name and surname:
Mgr. Andrea Hornáková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Hornáková
I.2 - Name
Andrea
I.3 - Degrees
Mgr., PhD.
I.4 - Year of birth
1986
I.5 - Name of the workplace
Biomedical Centre Martin, Jessenius faculty of medicine, UC in Martin
I.6 - Address of the workplace
Malá Hora 4C, 036 01 Martin
I.7 - Position
scientific researcher
I.8 - E-mail address
andrea.hornakova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/18095
I.11 - ORCID iD
https://orcid.org/0000-0003-3071-4947

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty od natural sciences Comenius University Bratislava
II.b - Year
2004-2007
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty od natural sciences Comenius University Bratislava
II.b - Year
2007-2009
II.c - Study field and programme
Genetic toxicology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Jessenius faculty of medicine in Martin Comenius University Bratislava
II.b - Year
2009-2014
II.c - Study field and programme
gynecology and obstetrics
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
scientific researcher Jessenius faculty of medicine in Martin Comenius University Bratislava 2014-2021
scientific researcher Jessenius faculty of medicine in Martin Comenius University Bratislava 2022-current

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
67
VI.1.b - Over the last six years
11
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
21
VI.1.b - Over the last six years
9
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
265
VI.1.b - Over the last six years
112
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
246
VI.1.b - Over the last six years
111
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova (Hornakova) A, Kajo K, Lasabova Z, Plank L, Danko J. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep. 2013 Dec;30(6):2878-86. doi: 10.3892/or.2013.2752.

2

Holubeková V, Mendelová (Hornáková) A, Grendár M, Meršaková S, Kapustová I, Jašek K, Vaňochová A, Danko J, Lasabová Z. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncol Lett. 2016 Oct;12(4):2613-2621. doi: 10.3892/ol.2016.5004.

3

Mendelova (Hornakova) A, Holubekova V, Grendar M, Zubor P, Svecova I, Loderer D, Snahnicanova Z, Biringer K, Danko J, Lasabova Z. Association between 3'UTR polymorphisms in genes ACVR2A, AGTR1 and RGS2 and preeclampsia. Gen Physiol Biophys. 2018 Mar;37(2):185-192. doi: 10.4149/gpb_2017028.

4

Hornakova A, Kolkova Z, Holubekova V, Loderer D, Lasabova Z, Biringer K, Halasova E. Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of Preeclampsia. Genet Test Mol Biomarkers. 2020 Jun;24(6):321-327. doi: 10.1089/gtmb.2019.0264.

5

Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, Loderer D, Zigo I, Biringer K, Hornakova A. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics (Basel). 2021 Mar 8;11(3):476. doi: 10.3390/diagnostics11030476.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Hornakova A, Kolkova Z, Holubekova V, Loderer D, Lasabova Z, Biringer K, Halasova E. Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of Preeclampsia. Genet Test Mol Biomarkers. 2020 Jun;24(6):321-327. doi: 10.1089/gtmb.2019.0264.

2

Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, Loderer D, Zigo I, Biringer K, Hornakova A. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics (Basel). 2021 Mar 8;11(3):476. doi: 10.3390/diagnostics11030476.

3

Kudelova E, Smolar M, Holubekova V, Hornakova A, Dvorska D, Lucansky V, Koklesova L, Kudela E, Kubatka P. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. Int J Mol Sci. 2022 Nov 29;23(23):14937. doi: 10.3390/ijms232314937.

4

Lucansky V, Samec M, Burjanivova T, Lukacova E, Kolkova Z, Holubekova V, Turyova E, Hornakova A, Zaborsky T, Podlesniy P, Reizigova L, Dankova Z, Novakova E, Pecova R, Calkovska A, Halasova E. Comparison of the methods for isolation and detection of SARS-CoV-2 RNA in municipal wastewater. Front Public Health. 2023 Mar 7;11:1116636. doi: 10.3389/fpubh.2023.1116636.

5

Loderer D, Hornáková A, Tobiášová K, Lešková K, Halašová E, Danková Z, Biringer K, Kúdela E, Rokos T, Dzian A, Miklušica J, Mikolajčík P, Smolár M, Plank L, Grendár M. Comparison of next‑generation sequencing quality metrics and concordance in the detection of cancer‑specific molecular alterations between formalin‑fixed paraffin‑embedded and fresh‑frozen samples in comprehensive genomic profiling with the Illumina® TruSight Oncology 500 assay. Exp Ther Med. 2025 Feb 4;29(4):64. doi: 10.3892/etm.2025.12814.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV-17-0037: Development of novel in vitro models for amyotrophic lateral sclerosis and testing the safety of human induced pluripotent stem cell-derived neural precursors.

2

VEGA 1/0272/19: Application of circulating miRNA as a potential biomarkers of pregnancy complications.

3

ITMS2014+: 313011V446 „Integrative strategy in the development of personalized medicine for selected malignancies and its impact on quality of life.“

4

09I03-03-V04-00228: Epigenetic changes in the developmentof cervical cancer.

5

APVV-23-0428: The role of the vaginal microbiome and the immune system in the process of HPV- induced cervical carcinogenesis.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-27